Literature DB >> 21208221

Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.

A Groffik1, H Mitzel-Kaoukhov, M Magerl, M Maurer, P Staubach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21208221     DOI： 10.1111/j.1398-9995.2010.02472.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  11 in total

Review 1.  Biologic agents in the treatment of urticaria.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

Review 2.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

3.  [Urticaria. Basic knowledge for the ENT specialist].

Authors:  V Daut; P Staubach; K Hörmann; L Klimek; O Pfaar
Journal:  HNO       Date:  2012-05       Impact factor: 1.284

4.  Omalizumab in treatment-resistant chronic spontaneous urticaria.

Authors:  Kiran V Godse
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

5.  Omalizumab for chronic urticaria: a case series and overview of the literature.

Authors:  Ilya Ivyanskiy; Carsten Sand; Simon Francis Thomsen
Journal:  Case Rep Dermatol       Date:  2012-01-30

Review 6.  Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Authors:  Kiran Godse; Abhishek De; Vijay Zawar; Bela Shah; Mukesh Girdhar; Murlidhar Rajagopalan; D S Krupashankar
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

7.  Treatment of chronic spontaneous urticaria.

Authors:  Allen P Kaplan
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-14       Impact factor: 5.764

8.  Effects of omalizumab treatment in patients with refractory chronic urticaria.

Authors:  Young-Hee Nam; Joo-Hee Kim; Hyun Jung Jin; Eui-Kyung Hwang; Yoo-Seob Shin; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-04-20       Impact factor: 5.764

Review 9.  Efficacy of Treatment of Non-hereditary Angioedema.

Authors:  Mignon van den Elzen; M F C L Go; A C Knulst; M A Blankestijn; H van Os-Medendorp; H G Otten
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 10.  Anti-IgE Treatment for Disorders Other Than Asthma.

Authors:  Jeffrey Stokes
Journal:  Front Med (Lausanne)       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.